You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

ETODOLAC - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for etodolac and what is the scope of patent protection?

Etodolac is the generic ingredient in three branded drugs marketed by Ani Pharms, Apotex, Biopharm, Chartwell Molecules, Mylan, Sandoz, Taro, Wyeth Pharms Inc, Actavis Elizabeth, Bayshore Pharms Llc, Teva, Watson Labs Florida, Zydus Pharms, Amneal Pharms Co, Apotex Inc, Edenbridge Pharms, Ivax Sub Teva Pharms, Oxford Pharms, Ranbaxy Labs Ltd, Shree Hari Intl, Taro Pharm Inds, and Watson Labs, and is included in thirty-nine NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-three drug master file entries for etodolac. Thirty-one suppliers are listed for this compound.

Drug Prices for ETODOLAC

See drug prices for ETODOLAC

Drug Sales Revenue Trends for ETODOLAC

See drug sales revenues for ETODOLAC

Recent Clinical Trials for ETODOLAC

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Kutahya Health Sciences UniversityPhase 4
Memorial Sloan Kettering Cancer CenterN/A
Apsen Farmaceutica S.A.Phase 3

See all ETODOLAC clinical trials

Pharmacology for ETODOLAC
Medical Subject Heading (MeSH) Categories for ETODOLAC

US Patents and Regulatory Information for ETODOLAC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Oxford Pharms ETODOLAC etodolac TABLET;ORAL 074819-002 Apr 28, 1998 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Zydus Pharms ETODOLAC etodolac TABLET, EXTENDED RELEASE;ORAL 091134-002 Jan 23, 2014 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Bayshore Pharms Llc ETODOLAC etodolac TABLET, EXTENDED RELEASE;ORAL 212263-001 Nov 24, 2020 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ETODOLAC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms Inc LODINE etodolac TABLET;ORAL 018922-004 Jul 29, 1993 ⤷  Try a Trial ⤷  Try a Trial
Wyeth Pharms Inc LODINE etodolac CAPSULE;ORAL 018922-002 Jan 31, 1991 ⤷  Try a Trial ⤷  Try a Trial
Wyeth Pharms Inc LODINE XL etodolac TABLET, EXTENDED RELEASE;ORAL 020584-001 Oct 25, 1996 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.